These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-004561-34 Tranexamic acid to elderly patients undergoing combined AVR and CABG surgery. not-yet-due
No trial status on register 2006-006469-17 A multicenter study to investigate the Sensitivity and Specificity of Aridol (Mannitol)Challenge as compared with Methacholine Challenge to predict a diagnosis of Asthma by a Specialist Pulmonologist ... bad-data
Ongoing 2008-004106-13 An Open-Label, Randomized, Multicenter Phase II Trial Comparing the Depletion of Malignant Stem Cells with Dasatinib vs. Imatinib in Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemi... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022897-14 A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study. 2014-09-01 bad-data
Not reported 2011-002203-15 Metformin treatment of pregnant PCOS women and prevention of late miscarriages and preterm birth 2017-10-02 due-trials
Ongoing 2011-005989-38 A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ALPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA not-yet-due
Not reported 2012-000248-91 Endoscopic block of the sphenopalatine ganglion with botulinum toxin in intractable cluster headache. Safety issues. 2014-09-09 due-trials
Ongoing 2012-001578-26 An international, multicentre, open randomised parallel group trial comparing a two step approach to cancer pain relief with the standard three step approach of the WHO analgesic ladder in patients wi... not-yet-due
Ongoing 2012-004381-18 Treatment of morbid obesity through intra-gastric injections of Botulinum toxin A: A pilot study not-yet-due
Ongoing 2013-001237-41 A Randomized Phase III Study Comparing Maintenance Pemetrexed Therapy After Induction Chemotherapy Versus Pemetrexed at Progression in Advanced Non-Small-Cell Lung Cancer not-yet-due
Ongoing 2013-002282-19 A randomised, open-label trial of a Multimodal Intervention (Exercise, Nutrition and Anti-inflammatory Medication) plus standard care versus standard care alone to prevent / attenuate cachexia in adva... not-yet-due
Ongoing 2014-001852-43 Botulinum toxin type A block of the sphenopalatine ganglion in chronic migraine. Safety issues not-yet-due
Ongoing 2014-002539-32 The WE Study - Walking Easier with cerebral palsy not-yet-due
Ongoing 2014-004075-23 A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer not-yet-due
Ongoing 2015-000295-94 Use of long acting opioids for pre- and postoperative analgesia in primary not-yet-due
Ongoing 2015-004377-33 Botulinum toxin type A Block for the sphenopalatine ganglion in chronic rhinosinusitis With nasal polyposis not-yet-due
Ongoing 2015-004463-37 ACUTE AND LONG-TERM EFFECTS OF INTRANASAL OXYTOCIN IN ALCOHOL WITHDRAWAL AND DEPENDENCE: A PROSPECTIVE RANDOMIZED PARALLEL GROUP PLACEBO-CONTROLLED TRIAL not-yet-due
Ongoing 2015-005306-11 Pharmacological treatment of insomnia in palliative care not-yet-due
Ongoing 2016-000326-19 Treatment of obesity in adolescents by endoscopic injection of Botulinum toxin A - A randomised, double blind, placebo-controlled phase II-trial followed by an open-label cohort-controlled extension not-yet-due
Ongoing 2016-004072-22 NTNU Intranasal Naloxone Trial Double blinded, double dummy, randomised controlled trial of intranasal naloxone for pre hospital use not-yet-due
Ongoing 2016-004213-28 Botulinum toxin type A block of the otic ganglion in chronic cluster headache. Safety issues. not-yet-due
Ongoing 2017-004572-62 A randomized phase II study comparing atezolizumab after concurrent chemo-radiotherapy with chemo-radiotherapy alone in limited disease small-cell lung cancer not-yet-due